辣根過氧化物市場 - 全球產業規模、佔有率、趨勢、機會、預測：按產品類型、應用、最終用途、地區和競爭對手分類，2021-2031年

全球辣根過氧化物酶市場預計將從 2025 年的 7,005 萬美元成長到 2031 年的 1.1067 億美元，複合年成長率為 7.92%。

辣根過氧化物酶 (HRP) 是一種從辣根根中提取的血紅素蛋白酶，因其在過氧化氫存在下能夠氧化基材並增強微弱訊號的特性，被廣泛應用於蛋白質印跡、酶聯免疫吸附試驗 (ELISA) 和免疫組織化學等生物化學應用中。該市場的成長主要受以下因素驅動：全球感染疾病和慢性病發病率的上升導致對高靈敏度診斷試劑的需求持續成長；以及藥物研發活動顯著增加，這些活動需要可靠的檢測試劑。與實驗室自動化等一般趨勢不同，這些促進因素代表了生物分析中固有的核心需求。

限制市場成長的主要障礙之一是原料供應鏈的脆弱性。由於生產嚴重依賴辣根的農業產量和質量，而辣根對環境條件十分敏感，這種依賴性可能造成生產瓶頸。 MedTech Europe 強調了依賴此類關鍵酶試劑的行業的經濟重要性，並預測到 2024 年歐洲醫療技術市場規模將達到約 1700 億歐元。這一數字反映了實驗室和診斷行業的龐大規模，這些行業高效運作依賴於辣根過氧化物酶等關鍵成分的穩定供應。

市場促進因素

慢性疾病和感染疾病率的上升是辣根過氧化物酶的主要市場促進因素，也因此迫切需要用於疾病監測和早期檢測的有效診斷設備。這種酶是免疫組織化學和酵素免疫分析法中的關鍵成分，它透過與抗體結合，使與複雜病理相關的目標抗原可視化。這些檢測的需求與惡性腫瘤病例的增加密切相關，因為惡性腫瘤需要精確的組織學檢查以製定治療策略。例如，美國癌症協會於2024年1月發布的《2024年癌症事實與數據》報告預測，美國新增癌症病例數將首次超過200萬例，顯示臨床病理學領域對可靠的生物標記檢測試劑的需求日益成長。

同時，隨著生物技術和製藥領域研發投入的不斷增加，這種酵素在高通量篩檢和藥物發現的應用也日益廣泛。基於過氧化物酶的檢測方法被廣泛應用於新型生物製藥的研發，以驗證治療效果和蛋白質交互作用。產業領導者為加速監管核准和推動臨床試驗，投入巨資，推動了這一趨勢的發展。根據美國製藥製造商協會（PhRMA）於2024年8月發布的《2024年PhRMA年度會員調查報告》，其會員公司在2023會計年度的研發累計創下歷史新高，達到1,030億美元。此外，試劑在感染疾病領域的應用也持續成長。世界衛生組織（WHO）在2024年報告稱，去年全球約有820萬人新確診結核病，這表明全球衛生監測領域對酵素試劑的需求將持續存在。

市場挑戰

原料供應鏈的脆弱性是全球辣根過氧化物酶市場成長的一大障礙。由於這種酶直接從辣根根部提取，因此該行業本質上依賴環境穩定性和農業週期。極端天氣事件，例如嚴重洪災和長期乾旱，會大幅降低作物產量並降低根部質量，導致提取所需的活性生質能短缺。這種生物限制使得需要可靠試劑的診斷試劑生產商面臨不穩定的供應基礎，直接阻礙了市場成長和可預測性。

這種不穩定性因種植的地理集中而進一步加劇。根據伊利諾州農業部2024年的報告顯示，該州生產的辣根佔全美總產量的三分之二以上。如此高度集中的種植意味著，單一區域的氣候變遷可能會影響全球重要的原料來源。因此，這種瓶頸限制了酵素生產所需基本原料的供應，導致市場供應波動，並阻礙了產業的持續發展。

市場趨勢

向重組生產技術的轉變正在從根本上改變全球辣根過氧化物酶市場，解決了傳統農業提取方式存在的許多嚴重問題。製造商正逐步放棄對辣根根莖的依賴，轉而採用合成生物學方法，以確保能夠大規模、穩定地供應用於精準免疫檢測的高純度酵素。這項策略轉變使供應商能夠在滿足現代診斷所需的嚴格品質標準的同時，降低環境風險。例如，默克集團在2024年4月發布的新聞稿《默克投資超過3億歐元在德國新建生命科學研究中心》中宣布，將投資超過3億歐元建設專門用於探索重組蛋白和抗體生產解決方案的設施，旨在確保未來的生物技術生產能力。

同時，將辣根過氧化物酶 (HRP) 整合到微流體即時檢測 (POC) 系統中，標誌著分散式檢查領域的重大技術進步。這些微型平台利用該酵素的快速反應特性，在攜帶式設備中實現了檢查室層級的靈敏度，從而能夠在標準醫院環境之外實現即時臨床決策。這些平台的研發進展正得到專款的積極推動，以加速產品上市。根據 FinSMEs 於 2024 年 11 月發表的一篇報導「新型微型裝置公司從 NIH RADx Tech資金籌措額外 270 萬美元資助」的文章，該公司獲得了 268 萬美元的資金，用於加速高性能診斷工具的開發，這凸顯了強勁的資金流正在推動了強勁的資金流正在診斷行業微流體技術的成長。

目錄

第1章概述

第2章：調查方法

第3章執行摘要

第4章：客戶心聲

第5章：全球辣根過氧化物市場展望

• 市場規模及預測
  • 按金額
• 市佔率及預測
  • 產品類型（一級、二級、三級、其他）
  • 依應用領域（免疫檢測、生物感測器等）
  • 依最終用途（醫院/診所、製藥/生物技術、學術/研究機構、其他）
  • 按地區
  • 按公司（2025 年）
• 市場地圖

第6章：北美辣根過氧化物市場展望

• 市場規模及預測
• 市佔率及預測
• 北美洲：國別分析
  • 美國
  • 加拿大
  • 墨西哥

第7章：歐洲辣根過氧化物市場展望

• 市場規模及預測
• 市佔率及預測
• 歐洲：國別分析
  • 德國
  • 法國
  • 英國
  • 義大利
  • 西班牙

第8章：亞太地區辣根過氧化物市場展望

• 市場規模及預測
• 市佔率及預測
• 亞太地區：國別分析
  • 中國
  • 印度
  • 日本
  • 韓國
  • 澳洲

第9章：中東和非洲辣根過氧化物市場展望

• 市場規模及預測
• 市佔率及預測
• 中東與非洲：國別分析
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 南非

第10章：南美洲辣根過氧化物市場展望

• 市場規模及預測
• 市佔率及預測
• 南美洲：國別分析
  • 巴西
  • 哥倫比亞
  • 阿根廷

第11章 市場動態

• 促進因素
• 任務

第12章 市場趨勢與發展

• 併購
• 產品發布
• 近期趨勢

第13章：全球辣根過氧化物市場：SWOT分析

第14章：波特五力分析

• 產業競爭
• 新進入者的潛力
• 供應商的議價能力
• 顧客權力
• 替代品的威脅

第15章 競爭格局

• Abcam Limited
• Thermo Fisher Scientific, Inc.
• Bio-Rad Laboratories Inc.
• Merck KGaA
• Baduhenna Topco Limited
• Takara Bio Inc.
• Promega Corporation
• GenScript Biotech Corporation
• F. Hoffmann-La Roche Ltd
• TOYOBO Co., Ltd.

第16章 策略建議

第17章：關於研究公司及免責聲明

The Global Horseradish Peroxidase Market is projected to expand from a valuation of USD 70.05 Million in 2025 to reach USD 110.67 Million by 2031, progressing at a CAGR of 7.92%. Horseradish Peroxidase (HRP), a hemoprotein enzyme derived from the roots of the horseradish plant, is extensively employed in biochemical applications including Western blotting, ELISA, and immunohistochemistry due to its capacity to enhance weak signals by oxidizing substrates in the presence of hydrogen peroxide. The market is primarily propelled by the rising global incidence of infectious and chronic diseases, which generates a continuous need for sensitive diagnostic assays, alongside substantial increases in pharmaceutical research activities that demand dependable detection reagents; these drivers are specific core necessities for biological analysis, distinct from general trends like laboratory automation.

One significant hurdle restricting market growth is the fragility of the raw material supply chain, as manufacturing relies heavily on the agricultural output and quality of horseradish roots, which are sensitive to environmental conditions. This dependency creates potential bottlenecks in production. Highlighting the economic significance of the sectors relying on such critical enzymatic reagents, MedTech Europe estimated in 2024 that the European medical technology market was worth approximately €170 billion. This figure illustrates the massive scale of the laboratory and diagnostic industries that depend on stable supplies of essential components like horseradish peroxidase to function effectively.

Market Driver

The escalating incidence of chronic and infectious diseases serves as a major driver for the horseradish peroxidase market, creating an urgent need for effective diagnostic instruments for disease monitoring and early detection. This enzyme acts as a vital element in immunohistochemistry and enzyme-linked immunosorbent assays, where it bonds with antibodies to reveal target antigens linked to complex medical conditions. The requirement for these assays aligns closely with the increasing burden of malignancies that demand exact histological examination for treatment strategies. For instance, the American Cancer Society's 'Cancer Facts & Figures 2024' report from January 2024 projected that new cancer cases in the United States would surpass 2 million for the first time, indicating a heightened demand for dependable biomarker detection reagents in clinical pathology.

Concurrently, rising expenditure in biotechnology and pharmaceutical research and development is broadening the application of this enzyme in high-throughput screening and drug discovery. Laboratories widely utilize peroxidase-based detection methods to confirm therapeutic efficacy and protein interactions during the creation of new biologics, a trend backed by massive investments from leading industry figures to speed up regulatory approvals and clinical pipelines. According to the '2024 PhRMA Annual Membership Survey' published by the Pharmaceutical Research and Manufacturers of America in August 2024, member companies declared a record-breaking $103 billion investment in R&D for 2023. Additionally, the infectious disease sector continues to drive reagent use; the World Health Organization noted in 2024 that roughly 8.2 million individuals were newly diagnosed with tuberculosis worldwide in the previous year, highlighting the enduring need for enzymatic reagents in global health monitoring.

Market Challenge

The fragility of the raw material supply chain poses a significant barrier to the growth of the Global Horseradish Peroxidase Market. Because the enzyme is obtained directly from horseradish plant roots, the industry is inherently dependent on environmental stability and agricultural cycles. Unfavorable weather patterns, such as severe flooding or extended droughts, can severely reduce crop harvests and degrade root quality, resulting in deficits of the high-activity biomass essential for extraction. This biological limitation establishes a volatile supply infrastructure for diagnostic manufacturers who need reliable reagent access, thereby directly impeding market growth and predictability.

This instability is greatly exacerbated by the dense geographic centralization of the crop's farming. As reported by the Illinois Farm Bureau in 2024, the state of Illinois was responsible for producing over two-thirds of the total horseradish supply for the United States. Such extreme concentration implies that a solitary regional climate incident can interfere with the primary global source of the raw material. As a result, this bottleneck restricts the availability of the fundamental base needed for the enzyme, compelling the market to struggle with oscillating supply volumes and obstructing consistent industrial development.

Market Trends

The shift toward recombinant production techniques is radically transforming the Global Horseradish Peroxidase Market by resolving the severe vulnerabilities associated with agricultural extraction. Manufacturers are progressively abandoning reliance on horseradish roots in favor of synthetic biology methods, guaranteeing a scalable and steady supply of high-purity enzymes necessary for creating precise immunoassays. This strategic adjustment permits suppliers to alleviate environmental hazards while satisfying the rigorous quality benchmarks needed for modern diagnostics. For example, Merck KGaA announced in an April 2024 press release titled 'Merck Invests More Than € 300 Million in New Life Science Research Center in Germany' that it is investing over €300 million to build a facility focused on researching manufacturing solutions for recombinant proteins and antibodies, aiming to safeguard future biotechnological production capabilities.

At the same time, incorporating horseradish peroxidase into microfluidic Point-of-Care (POC) diagnostic systems marks a significant technological advancement toward decentralized testing. These miniature platforms utilize the enzyme's fast kinetics to provide laboratory-quality sensitivity within portable units, enabling instant clinical decisions beyond standard hospital settings. The progress of these platforms is receiving aggressive support through targeted funding to hasten their market readiness. According to a November 2024 article by FinSMEs titled 'Novel Microdevices Receives Approx. $2.7M Follow on Funding from NIH RADx Tech', the company obtained $2.68 million to further its high-performance diagnostic tool, highlighting the strong flow of capital driving the growth of microfluidic technologies in the diagnostics industry.

Key Market Players

• Abcam Limited
• Thermo Fisher Scientific, Inc.
• Bio-Rad Laboratories Inc.
• Merck KGaA
• Baduhenna Topco Limited
• Takara Bio Inc.
• Promega Corporation
• GenScript Biotech Corporation
• F. Hoffmann-La Roche Ltd
• TOYOBO Co., Ltd.

Report Scope

In this report, the Global Horseradish Peroxidase Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Horseradish Peroxidase Market, By Product Type

• Grade I
• Grade II
• Grade III
• Others

Horseradish Peroxidase Market, By Application

• Immunoassays
• Biosensors
• Others

Horseradish Peroxidase Market, By End-use

• Hospitals and Clinics
• Pharmaceuticals and Biotech
• Academic and Research
• Others

Horseradish Peroxidase Market, By Region

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Horseradish Peroxidase Market.

Available Customizations:

Global Horseradish Peroxidase Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Horseradish Peroxidase Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product Type (Grade I, Grade II, Grade III, Others)
  • 5.2.2. By Application (Immunoassays, Biosensors, Others)
  • 5.2.3. By End-use (Hospitals and Clinics, Pharmaceuticals and Biotech, Academic and Research, Others)
  • 5.2.4. By Region
  • 5.2.5. By Company (2025)
• 5.3. Market Map

6. North America Horseradish Peroxidase Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Product Type
  • 6.2.2. By Application
  • 6.2.3. By End-use
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Horseradish Peroxidase Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Product Type
      • 6.3.1.2.2. By Application
      • 6.3.1.2.3. By End-use
  • 6.3.2. Canada Horseradish Peroxidase Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Product Type
      • 6.3.2.2.2. By Application
      • 6.3.2.2.3. By End-use
  • 6.3.3. Mexico Horseradish Peroxidase Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Product Type
      • 6.3.3.2.2. By Application
      • 6.3.3.2.3. By End-use

7. Europe Horseradish Peroxidase Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Product Type
  • 7.2.2. By Application
  • 7.2.3. By End-use
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Horseradish Peroxidase Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Product Type
      • 7.3.1.2.2. By Application
      • 7.3.1.2.3. By End-use
  • 7.3.2. France Horseradish Peroxidase Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Product Type
      • 7.3.2.2.2. By Application
      • 7.3.2.2.3. By End-use
  • 7.3.3. United Kingdom Horseradish Peroxidase Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Product Type
      • 7.3.3.2.2. By Application
      • 7.3.3.2.3. By End-use
  • 7.3.4. Italy Horseradish Peroxidase Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Product Type
      • 7.3.4.2.2. By Application
      • 7.3.4.2.3. By End-use
  • 7.3.5. Spain Horseradish Peroxidase Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Product Type
      • 7.3.5.2.2. By Application
      • 7.3.5.2.3. By End-use

8. Asia Pacific Horseradish Peroxidase Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Product Type
  • 8.2.2. By Application
  • 8.2.3. By End-use
  • 8.2.4. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Horseradish Peroxidase Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Product Type
      • 8.3.1.2.2. By Application
      • 8.3.1.2.3. By End-use
  • 8.3.2. India Horseradish Peroxidase Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Product Type
      • 8.3.2.2.2. By Application
      • 8.3.2.2.3. By End-use
  • 8.3.3. Japan Horseradish Peroxidase Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Product Type
      • 8.3.3.2.2. By Application
      • 8.3.3.2.3. By End-use
  • 8.3.4. South Korea Horseradish Peroxidase Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Product Type
      • 8.3.4.2.2. By Application
      • 8.3.4.2.3. By End-use
  • 8.3.5. Australia Horseradish Peroxidase Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Product Type
      • 8.3.5.2.2. By Application
      • 8.3.5.2.3. By End-use

9. Middle East & Africa Horseradish Peroxidase Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Product Type
  • 9.2.2. By Application
  • 9.2.3. By End-use
  • 9.2.4. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Horseradish Peroxidase Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Product Type
      • 9.3.1.2.2. By Application
      • 9.3.1.2.3. By End-use
  • 9.3.2. UAE Horseradish Peroxidase Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Product Type
      • 9.3.2.2.2. By Application
      • 9.3.2.2.3. By End-use
  • 9.3.3. South Africa Horseradish Peroxidase Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Product Type
      • 9.3.3.2.2. By Application
      • 9.3.3.2.3. By End-use

10. South America Horseradish Peroxidase Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Product Type
  • 10.2.2. By Application
  • 10.2.3. By End-use
  • 10.2.4. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Horseradish Peroxidase Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Product Type
      • 10.3.1.2.2. By Application
      • 10.3.1.2.3. By End-use
  • 10.3.2. Colombia Horseradish Peroxidase Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Product Type
      • 10.3.2.2.2. By Application
      • 10.3.2.2.3. By End-use
  • 10.3.3. Argentina Horseradish Peroxidase Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Product Type
      • 10.3.3.2.2. By Application
      • 10.3.3.2.3. By End-use

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Horseradish Peroxidase Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Abcam Limited
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Thermo Fisher Scientific, Inc.
• 15.3. Bio-Rad Laboratories Inc.
• 15.4. Merck KGaA
• 15.5. Baduhenna Topco Limited
• 15.6. Takara Bio Inc.
• 15.7. Promega Corporation
• 15.8. GenScript Biotech Corporation
• 15.9. F. Hoffmann-La Roche Ltd
• 15.10. TOYOBO Co., Ltd.

16. Strategic Recommendations

17. About Us & Disclaimer